Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
GeoPark Sells 20% Stake to Colden Investments in $107 Million Private Placement
Cleary Gottlieb has advised GeoPark Limited. GeoPark Limited has successfully completed a private placement of $107 million of its common shares to Colden Investments S.A., an...
Honeywell Aerospace Completes $16 Billion Bond Offering and Related Financing Transactions
Cleary Gottlieb has advised Honeywell International Inc. in the transaction. Honeywell International Inc. completed a significant financial transaction involving its wholly-owned subsidiary, Honeywell Aerospace Inc., through...
Edison International and Southern California Edison Launch Cash Tender Offers for Preferred Securities
Cleary Gottlieb has advised Barclays Capital Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC, and Santander US Capital Markets LLC. Edison International and its subsidiary,...
White Mountains Announces $300 Million Tender Offer for Outstanding Shares
Cravath, Swaine & Moore LLP has advised White Mountains Insurance Group Ltd. Cleary Gottlieb has advised the dealer managers, including BofA Securities Inc. and Barclays Capital...
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Iovance Biotherapeutics’ US$211 Million Common Stock Offering
DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...
Janux Therapeutics’ $60 Million Offering of Common Stock and Pre-Funded Warrants
Cooley advised Janux, and Latham & Watkins advised the underwriter on the offering. Janux Therapeutics, Inc. (Nasdaq: JANX) has announced the pricing of an underwritten offering of...
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
Reneo Pharmaceuticals’ Common Stock Offering
Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents. Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of...
Mineralys Therapeutics’ $192 Million Initial Public Offering
Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters. Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public...
Longboard Pharmaceuticals’ $20 Million Common Stock Offering
Cooley advised Longboard Pharmaceuticals on the offering, and Latham & Watkins advised the underwriters involved. Longboard Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public...